COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Design and Manufacture of Pharmaceutical Tablets - 1st Edition - ISBN: 9780128021828, 9780128021873

Design and Manufacture of Pharmaceutical Tablets

1st Edition

Author: Reynir Eyjolfsson
eBook ISBN: 9780128021873
Paperback ISBN: 9780128021828
Imprint: Academic Press
Published Date: 9th October 2014
Page Count: 68
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Design and Manufacture of Pharmaceutical Tablets offers real world solutions and outcomes of formulation and processing challenges of pharmaceutical tablets. This book includes numerous practical examples related to actual formulations that have been validated and marketed and covers important data in the areas of stability, dissolution, bioavailibity and processing. It provides important background and theoretical information on design and manufacturing and includes a full section dedicated to design experimental methodology and statistics. In addition, this book offers a a general discussion of excipients used in proper tablet design along with practical examples related to excipients. Drug development scientists in industry and academia, as well as students in the pharmaceutical sciences will greatly benefit from the practical knowledge and case examples provided throughout this book.

Key Features

  • Incorporates important mathematical models and computational applications
  • Includes unique content on central composite design and augmented simplex lattice
  • Provides background on important design principles with emphasis on quality-based design (QBD) of pharmaceutical dosage forms


Drug formulation and manufacturing scientists in the pharmaceutical industry; academics and professors engaged in research or teaching on tablet design and manufacturing and graduate students in the pharmaceutical sciences taking courses in pharmaceutics

Table of Contents

  • Dedication
  • Preface
  • Abbreviations
  • Chapter One: Introduction
    • Abstract
    • 1.1. General considerations [1, 2]
    • 1.2. Particle sizes [3]
    • 1.3. Excipients [4]
    • 1.4. Equipment
    • 1.5. Mixing of pharmaceutical powders [5]
    • 1.6. Design of experiments [6–9]
  • Chapter Two: Conventional-Release (CR) Tablets
    • Abstract
    • 2.1. Low-dose tablet by direct compression (DC)
    • 2.2. High-dose tablet by direct compression
    • 2.3. Low-solubility API, low-dose tablet by wet granulation (WG) [1]
    • 2.4. Soluble API, low-dose tablet by wet granulation
    • 2.5. Low-solubility API, high-dose tablet by wet granulation
    • 2.6. Soluble API, high-dose tablet by wet granulation [2]
  • Chapter Three: Slow-Release (SR) Tablets
    • Abstract
    • 3.1. Slow-release tablet using a lipophilic release control agent
    • 3.2. Slow-release tablet using Eudragit and Methocel as release control agents
    • 3.3. Slow-release tablet using a mixture of Methocels as release control agent [1]
  • Index


No. of pages:
© Academic Press 2014
9th October 2014
Academic Press
eBook ISBN:
Paperback ISBN:

About the Author

Reynir Eyjolfsson

Dr. Eyjolfsson entered pharmacy in 1959, having studied at the University of Iceland and then at the Pharmaceutical University of Denmark, Copenhagen 1961-1964 (MsPharm 1964). Dr. Eyjolfsson earned a Ph.D. in the chemistry of natural product from same university in 1968. He moved to Iceland in 1971 and has worked with drug formulation science at Pharmaco, Delta, Actavis until 2010. Dr. Eyjolfsson is an author of approximately 30 scientific papers in peer reviewed journals mainly on phytochemistry and pharmaceutics. He has designed many different dosage forms but mostly conventional tablets and slow release tablets.

Affiliations and Expertise

M.Sc.Pharm, PhD. Retired; previously drug formulation scientist and drug development manager, Actavis, Harnarfjordur, Iceland


" would be of most benefit to persons with a solid grounding in the theory of pharmaceutical development who are starting to work in the area of solid dosage form design." --The Pharmaceutical Journal, January 2015

Ratings and Reviews